A new injectable method for contraception and HIV prevention.
Ultra-Long-Acting Polymeric Injectable Multi-Purpose Prevention Technology for Contraception and HIV Prevention
This study is working on a new long-lasting injection that helps women prevent both pregnancy and HIV, giving them more control over their health without needing to worry about taking a pill every day.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11064826 on NIH RePORTER |
What this research studies
This research focuses on developing a long-acting injectable formulation that can provide both contraception and HIV prevention, specifically designed for female use. The approach aims to create a multi-purpose prevention technology (MPT) that can be administered without the need for immediate sexual activity, enhancing women's control over their reproductive health. The methodology involves using innovative nano-formulations that release medication over extended periods, ensuring high efficacy and patient compliance. The study builds on existing data to overcome current limitations in combining multiple drugs into a single injection.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who are at risk of HIV infection and are seeking effective contraception methods.
Not a fit: Patients who are not at risk of HIV or do not require contraception may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide women with a reliable and convenient method for preventing both unplanned pregnancies and HIV infection.
How similar studies have performed: Previous research has shown promise with long-acting injectable formulations for HIV prevention, but this specific multi-purpose approach is novel.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Benhabbour, Soumya Rahima — Univ of North Carolina Chapel Hill
- Study coordinator: Benhabbour, Soumya Rahima
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.